{"id":511490,"date":"2021-07-09T16:54:26","date_gmt":"2021-07-09T20:54:26","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/c-o-r-r-e-c-t-i-o-n-haemonetics-corporation\/"},"modified":"2021-07-09T16:54:26","modified_gmt":"2021-07-09T20:54:26","slug":"c-o-r-r-e-c-t-i-o-n-haemonetics-corporation","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/c-o-r-r-e-c-t-i-o-n-haemonetics-corporation\/","title":{"rendered":"\/C O R R E C T I O N — Haemonetics Corporation\/"},"content":{"rendered":"
\n

PR Newswire<\/p>\n<\/p><\/div>\n

\n

In the news release, Haemonetics Sets Date for Publishing First Quarter Fiscal Year 2022 Results: August 11, 2021<\/span>, issued July 9, 2021<\/span> by Haemonetics Corporation over PR Newswire, we are advised by the company that the link to the webcast was incorrectly transmitted by PR Newswire. The complete, corrected release follows:<\/p>\n

Haemonetics Sets Date for Publishing First Quarter Fiscal Year 2022 Results: August 11, 2021<\/h3>\n

<\/p>\n

\n BOSTON<\/span>, July 9, 2021<\/span> \/PRNewswire\/ —\u00a0Haemonetics Corporation (NYSE: HAE) announced that the Company intends to publish first quarter fiscal year 2022 financial results at 6:00 am EDT on Wednesday, August 11, 2021<\/span>. The Company will hold a conference call with investors and analysts to discuss results and answer questions at 8:00 am EDT<\/span> on August 11<\/span>, 2021.\u00a0 <\/p>\n

\n

\n
\n \"\"
\n <\/a>\n <\/p>\n<\/p><\/div>\n

The call can be accessed with the following information:<\/p>\n

U.S. \/ Canada<\/span> toll free (877) 848-8880; International (716) 335-9512
Conference ID required for access: 1674067<\/p>\n

A live webcast of the call can be accessed on Haemonetics’ investor relations website. Webcast Link: https:\/\/edge.media-server.com\/mmc\/p\/i5w7z4hk<\/a><\/p>\n

A replay of the conference call and webcast will be available for one year beginning on August 11, 2021<\/span> at 11:00 a.m. EDT<\/span> using the conference call webcast link provided in this press release.<\/p>\n

\n About Haemonetics<\/b>\n <\/p>\n

Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative hematology products and solutions for customers to help them improve patient care and reduce the cost of healthcare. Our technologies address important medical markets: blood and plasma component collection, the surgical suite, and hospital transfusion services. To learn more about Haemonetics, visit www.haemonetics.com<\/a>. \u00a0 <\/p>\n

\n Investor Contact:\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0
<\/b>Olga Guyette,\u00a0Director-Investor Relations\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0
(781) 356-9763\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0
olga.guyette@haemonetics.com<\/a> \u00a0\u00a0\u00a0\u00a0\u00a0<\/p>\n

<\/div>\n

\n \"Cision\" View original content to download multimedia:https:\/\/www.prnewswire.com\/news-releases\/haemonetics-sets-date-for-publishing-first-quarter-fiscal-year-2022-results-august-11-2021-301328843.html<\/a><\/p>\n

SOURCE Haemonetics Corporation<\/p>\n<\/p><\/div>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

PR Newswire In the news release, Haemonetics Sets Date for Publishing First Quarter Fiscal Year 2022 Results: August 11, 2021, issued July 9, 2021 by Haemonetics Corporation over PR Newswire, we are advised by the company that the link to the webcast was incorrectly transmitted by PR Newswire. The complete, corrected release follows: Haemonetics Sets Date for Publishing First Quarter Fiscal Year 2022 Results: August 11, 2021 BOSTON, July 9, 2021 \/PRNewswire\/ —\u00a0Haemonetics Corporation (NYSE: HAE) announced that the Company intends to publish first quarter fiscal year 2022 financial results at 6:00 am EDT on Wednesday, August 11, 2021. The Company will hold a conference call with investors and analysts to discuss results and answer questions at 8:00 am EDT … <\/p>\n

Continue reading “\/C O R R E C T I O N — Haemonetics Corporation\/”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-511490","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\n\/C O R R E C T I O N - Haemonetics Corporation\/ - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/c-o-r-r-e-c-t-i-o-n-haemonetics-corporation\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"\/C O R R E C T I O N - Haemonetics Corporation\/ - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire In the news release, Haemonetics Sets Date for Publishing First Quarter Fiscal Year 2022 Results: August 11, 2021, issued July 9, 2021 by Haemonetics Corporation over PR Newswire, we are advised by the company that the link to the webcast was incorrectly transmitted by PR Newswire. The complete, corrected release follows: Haemonetics Sets Date for Publishing First Quarter Fiscal Year 2022 Results: August 11, 2021 BOSTON, July 9, 2021 \/PRNewswire\/ —\u00a0Haemonetics Corporation (NYSE: HAE) announced that the Company intends to publish first quarter fiscal year 2022 financial results at 6:00 am EDT on Wednesday, August 11, 2021. The Company will hold a conference call with investors and analysts to discuss results and answer questions at 8:00 am EDT … Continue reading "\/C O R R E C T I O N — Haemonetics Corporation\/"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/c-o-r-r-e-c-t-i-o-n-haemonetics-corporation\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-07-09T20:54:26+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/351568\/Haemonetics_Corporation_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/c-o-r-r-e-c-t-i-o-n-haemonetics-corporation\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/c-o-r-r-e-c-t-i-o-n-haemonetics-corporation\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"\\\/C O R R E C T I O N — Haemonetics Corporation\\\/\",\"datePublished\":\"2021-07-09T20:54:26+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/c-o-r-r-e-c-t-i-o-n-haemonetics-corporation\\\/\"},\"wordCount\":293,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/c-o-r-r-e-c-t-i-o-n-haemonetics-corporation\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/351568\\\/Haemonetics_Corporation_Logo.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/c-o-r-r-e-c-t-i-o-n-haemonetics-corporation\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/c-o-r-r-e-c-t-i-o-n-haemonetics-corporation\\\/\",\"name\":\"\\\/C O R R E C T I O N - Haemonetics Corporation\\\/ - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/c-o-r-r-e-c-t-i-o-n-haemonetics-corporation\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/c-o-r-r-e-c-t-i-o-n-haemonetics-corporation\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/351568\\\/Haemonetics_Corporation_Logo.jpg\",\"datePublished\":\"2021-07-09T20:54:26+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/c-o-r-r-e-c-t-i-o-n-haemonetics-corporation\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/c-o-r-r-e-c-t-i-o-n-haemonetics-corporation\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/c-o-r-r-e-c-t-i-o-n-haemonetics-corporation\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/351568\\\/Haemonetics_Corporation_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/351568\\\/Haemonetics_Corporation_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/c-o-r-r-e-c-t-i-o-n-haemonetics-corporation\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"\\\/C O R R E C T I O N — Haemonetics Corporation\\\/\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\/C O R R E C T I O N - Haemonetics Corporation\/ - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/c-o-r-r-e-c-t-i-o-n-haemonetics-corporation\/","og_locale":"en_US","og_type":"article","og_title":"\/C O R R E C T I O N - Haemonetics Corporation\/ - Market Newsdesk","og_description":"PR Newswire In the news release, Haemonetics Sets Date for Publishing First Quarter Fiscal Year 2022 Results: August 11, 2021, issued July 9, 2021 by Haemonetics Corporation over PR Newswire, we are advised by the company that the link to the webcast was incorrectly transmitted by PR Newswire. The complete, corrected release follows: Haemonetics Sets Date for Publishing First Quarter Fiscal Year 2022 Results: August 11, 2021 BOSTON, July 9, 2021 \/PRNewswire\/ —\u00a0Haemonetics Corporation (NYSE: HAE) announced that the Company intends to publish first quarter fiscal year 2022 financial results at 6:00 am EDT on Wednesday, August 11, 2021. The Company will hold a conference call with investors and analysts to discuss results and answer questions at 8:00 am EDT … Continue reading \"\/C O R R E C T I O N — Haemonetics Corporation\/\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/c-o-r-r-e-c-t-i-o-n-haemonetics-corporation\/","og_site_name":"Market Newsdesk","article_published_time":"2021-07-09T20:54:26+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/351568\/Haemonetics_Corporation_Logo.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/c-o-r-r-e-c-t-i-o-n-haemonetics-corporation\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/c-o-r-r-e-c-t-i-o-n-haemonetics-corporation\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"\/C O R R E C T I O N — Haemonetics Corporation\/","datePublished":"2021-07-09T20:54:26+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/c-o-r-r-e-c-t-i-o-n-haemonetics-corporation\/"},"wordCount":293,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/c-o-r-r-e-c-t-i-o-n-haemonetics-corporation\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/351568\/Haemonetics_Corporation_Logo.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/c-o-r-r-e-c-t-i-o-n-haemonetics-corporation\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/c-o-r-r-e-c-t-i-o-n-haemonetics-corporation\/","name":"\/C O R R E C T I O N - Haemonetics Corporation\/ - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/c-o-r-r-e-c-t-i-o-n-haemonetics-corporation\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/c-o-r-r-e-c-t-i-o-n-haemonetics-corporation\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/351568\/Haemonetics_Corporation_Logo.jpg","datePublished":"2021-07-09T20:54:26+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/c-o-r-r-e-c-t-i-o-n-haemonetics-corporation\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/c-o-r-r-e-c-t-i-o-n-haemonetics-corporation\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/c-o-r-r-e-c-t-i-o-n-haemonetics-corporation\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/351568\/Haemonetics_Corporation_Logo.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/351568\/Haemonetics_Corporation_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/c-o-r-r-e-c-t-i-o-n-haemonetics-corporation\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"\/C O R R E C T I O N — Haemonetics Corporation\/"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/511490","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=511490"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/511490\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=511490"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=511490"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=511490"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}